We’re happy to announce we’ll be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, #1616, will display a range of customizable cell-based contract assay services for life science and pharmaceutical organizations worldwide. We will also be displaying our new cellPrism® drug development platform that offers a broad spectrum of toxicology and immunology assays to help address your labs program challenges. Since 2007, we have worked with over 200 different companies to advance their understanding of the potency, efficacy and toxicity of their leading candidate therapies.
“An Ex Vivo Flow Cytometry Platform to Evaluate the Effects of Compounds on Lymphotoxicity in Multiple Species”
Date: March 16, 2017
Abstract: #3292, Poster: #261
“Impurity Qualification Strategy for the Cytostatic Clofarabine”
H. van der Woude1, A. Sesink1, T. van Achterberg1, E. Clarke2, and D. van den Dobbelsteen1.
1 Synthon Biopharmaceuticals B.V., Nijmegen, Netherlands and 2 ReachBio Research Labs, Seattle, WA.
Date: March 14, 2017
Author Attended: 11:15AM - 12:45PM
Abstract: #1697, Poster: #149